Results 111 to 120 of about 17,288 (263)

Efficacy & safety of Desmopressin in the treatment of pediatric nocturnal enuresis

open access: yesمجله كليه طب الكندي, 2014
Back ground: primary nocturnal enuresis (PNE) is a socially distressing condition that can be troubling for children & their families. It affects 15-26% of five years olds.
Ala’a Al-Deen
doaj  

Desmopressin (DDAVP)-induced pseudotumor cerebri [PDF]

open access: bronze, 2003
Daniel E. Neely   +2 more
openalex   +1 more source

Endothelial Function and Coagulant Factors in Growth Hormone-Treated Hypopituitary Adults Receiving Desmopressin [PDF]

open access: bronze, 2003
J. C. Smith   +8 more
openalex   +1 more source

PO39 | Bleeding events in Von Willebrand disease type 1 yearly treatable with desmopressin

open access: yesBleeding, Thrombosis and Vascular Biology
Background and Aims: Subcutaneous and intranasal desmopressin is safe and effective in type 1 VWD, and particularly convenient for pediatric use and home treatment.
doaj   +1 more source

Desmopressin and low-dose ACTH test in rheumatoid arthritis

open access: bronze, 1998
Luca Foppiani   +6 more
openalex   +1 more source

Desmopressin use for minimising perioperative allogeneic blood transfusion [PDF]

open access: green, 2004
Michael Desborough   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy